[Table/Fig-3]:
Clinical features.
| Feature | No. (%) | p-value | |
|---|---|---|---|
| Symptoms | Nasal mass | 5 (15.63%) | 0.0005 |
| Nasal obstruction | 13 (40.63%) | ||
| Epistaxis | 9 (28.13%) | ||
| Nasal discharge | 5 (15.63%) | ||
| Gross characteristics | Pedunculated | 11(34.38%) | 0.0964 |
| Sessile | 21 (65.63%) | ||
| Site of involvement | Nasal | 19 (59.38%) | 0.0042 |
| Nasopharyngeal | 7 (21.88%) | ||
| Nasal and nasopharyngeal | 5 (15.63%) | ||
| Disseminated | 1 (3.13%) | ||
| Site of primary attachment | Inferior turbinate | 6 (18.75%) | >0.05 |
| Septum | 7 (21.88%) | ||
| Middle turbinate | 1 (3.13%) | ||
| Middle meatus | 1 (3.13%) | ||
| Inferior turbinate | 2 (6.25%) | ||
| Multiple nasal attachments | 2 (6.25%) | ||
| Nasal and nasopharyngeal | 6 (18.75%) | ||
| Nasopharyngeal | 7 (21.88%) |